Etanercept

Caesarean

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S4894
R12925
Broms (Controls exposed to other treatments), 2020 Caesarean section 3 months (or more) before pregnancy or during pregnancy population based cohort retrospective exposed to other treatment, sick excluded Adjustment: No 1.17 [0.96;1.42] C
excluded (control group)
155/510   2,560/9,393 2,715 510
ref
S4895
R12930
Broms (Controls unexposed, disease free), 2020 Caesarean section 3 months (or more) before pregnancy or during pregnancy excluded population based cohort retrospective unexposed, disease free Adjustment: No 2.08 [1.72;2.51] C
excluded (exposition period)
155/510   281,654/1,623,483 281,809 510
ref
S4961
R13016
De Lorenzo (Controls unexposed, disease free), 2020 Caesarean at least 1st trimester retrospective cohort unexposed, disease free excluded Adjustment: No 6.00 [0.94;38.45] C
excluded (control group)
4/6   9/36 13 6
ref
S4960
R13010
De Lorenzo (Controls unexposed, sick), 2020 Caesarean at least 1st trimester excluded retrospective cohort unexposed, sick Adjustment: No 2.92 [0.47;18.37] C
excluded (exposition period)
4/6   13/32 17 6
ref
S4994
R13072
Drechsel, 2020 Caesarean section 1st trimester excluded prospective cohort unexposed, sick Adjustment: No 1.50 [0.37;6.12] C
excluded (exposition period)
4/9   23/66 27 9
ref
Total 0 studies NaN [NaN;NaN] 0 0
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

Sensitivity analysis